INS and type 1 diabetes mellitus: Adult patients included in the islet transplantation process usually have T1DM for more than 5 years, have no preserved endogenous insulin production with negative stimulated C-peptide levels (<0.3 ng/mL), and are prone to severe hypoglycemic episodes or exhibit glycemic instability despite adequate insulin therapy [3].